Clinical Trials · NCT03029351
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- University at Buffalo
- Enrollment
- 15
- Start date
- Jan 2017
- Locations
- 1 site, United States
- Primary endpoint
- Change From Baseline in Urinary Albuminuria Levels